Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.

Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.

Item
http://www.wikidata.org/entity/Q44838463
Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy.Post-HAART outcomes in pediatric populations: comparison of resource-limited and developed countriesSuboptimal immune reconstitution in vertically HIV infected children: a view on how HIV replication and timing of HAART initiation can impact on T and B-cell compartmentAntiretroviral therapy and mother-to-child transmission of HIV-1.Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy.Induction maintenance concept for HAART as initial treatment in HIV infected infants.Growth reconstitution following antiretroviral therapy and nutritional supplementation: systematic review and meta-analysis.Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens.Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic.Pediatric HIV: new opportunities to treat children.Role of non-nucleoside reverse transcriptase inhibitors in treating HIV-infected children.The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children.Antiretroviral resistance in HIV-infected Saudi children failing first-line highly active antiretroviral therapy.Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children.Pediatric HIV-1-specific cytotoxic T-lymphocyte responses suggesting ongoing viral replication despite combination antiretroviral therapy.
P2860

Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.

Item
http://www.wikidata.org/entity/Q44838463
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Highly active antiretroviral t ...... d and drug resistance outcome.
@en
Highly active antiretroviral t ...... d and drug resistance outcome.
@nl
type
label
Highly active antiretroviral t ...... d and drug resistance outcome.
@en
Highly active antiretroviral t ...... d and drug resistance outcome.
@nl
prefLabel
Highly active antiretroviral t ...... d and drug resistance outcome.
@en
Highly active antiretroviral t ...... d and drug resistance outcome.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Highly active antiretroviral t ...... ad and drug resistance outcome
@en
P2093
P304
P31
P356
10.1097/00002030-200401230-00013
P407
P433
P478
P50
P577
P698
P921